comparemela.com

Anchalee Avihingsanon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Multiple Studies Reinforce Biktarvy as Treatment for Diverse Range of Patients With HIV

The once-daily therapeutic agent is effective for pediatric patients and pregnant women with HIV.

Anchalee avihingsanonEva natukundaJared baetenResearch centerGilead sciencesClinical developmentClinical research centreDepartment of pediatricsThai red crossJoint clinical research centre

ALLIANCE trial shows positive HIV/HBV coinfection treatment data

SEATTLE — The ALLIANCE trial showed positive data on bictegravir/emtricitabine/tenofovir alafenamide treatment for HIV and hepatitis B coinfection while also providing data on treatment outcome predictors.

Anchalee avihingsanonBycaitlyn stulpinCaroll diberardinoResearch centerGilead sciences incOpportunistic infectionsThai red cross

Bictegravir-Based Treatment Wins for HIV/HBV Co-Infections

Head-to-head comparison in ALLIANCE trial favors use over dolutegravir-based combination

United statesFort pierceKrung thep mahanakhonEd susmanAnchalee avihingsanonResearch centerThai red cross

Landmark ALLIANCE Results Offer Tenofovir Guidance

Both regimens were equally effective for HIV control, but B/F/TAF produced better HBV results.

Krung thep mahanakhonUnited statesBabafemi taiwoAnchalee avihingsanonMedicine at northwestern university in evanstonResearch centreNetherlands australia thailand research collaborationAustralia thailand research collaborationThai red crossInfectious diseasesNorthwestern universityMedscape medical

Biktarvy® Demonstrates High Efficacy for a Broad Range of People Initiating Treatment for HIV, Including Those With HBV Coinfection

Biktarvy® Demonstrates High Efficacy for a Broad Range of People Initiating Treatment for HIV, Including Those With HBV Coinfection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFoster cityJacquie rossJared baetenAnchalee avihingsanonBrian plummerGilead sciencesResearch centerGilead sciences incExchange commissionGilead public affairsGilead on twitter sciencesClinical developmentWall streetHighlights potentialTreatment failure due

vimarsana © 2020. All Rights Reserved.